Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. GlobalData uses proprietary data and analytics to provide a comprehensive report on the implantable cardioverter defibrillators market in the Netherlands. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the implantable cardioverter defibrillators market in the Netherlands was Abbott Laboratories followed by Biotronik SE & Co, Boston Scientific and Medtronic.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless. Single Chamber ICD, Dual Chamber ICD and Subcutaneous ICD are tracked under this segment. A single chamber ICD attaches to one chamber of the heart i.e. , right ventricle, and monitors the electrical activity of that chamber. A dual chamber ICD monitors the electrical activity in two chambers of the heart (an atrium and a ventricle) and delivers electric pulses to one or both chambers in the event of an arrhythmia. The subcutaneous ICD (S-ICD) also known as leadless ICDs consists of an electrode and a pulse generator which functions without the placement of the electrical wires (leads) in the heart.
The implantable cardioverter defibrillators market in the Netherlands can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size implantable cardioverter defibrillators in the Netherlands, buy the report here.